Colorado life sciences companies raise $750M in 2019, Pfizer acquisition of Array BioPharma brings total to $12.1B
DENVER -- Colorados life sciences ecosystem raised $750 million in 2019, with funds from federal and state grants, successful financing rounds and acquisitions. The record-breaking acquisition of... Read More
Wednesday December 18, 2019
CBSA delivers awards to top bioscience leaders
DENVER -- Colorado BioScience Association celebrated the companies and organizations developing life-saving breakthroughs at its Annual Awards Dinner held Nov. 7 at the Hyatt Regency in Denver.... Read More
Tuesday November 12, 2019
Array BioPharma: Cancer drug showing favorable results in phase 3 trials
BOULDER -- Array BioPharma Inc. (Nasdaq: ARRY) today announced the presentation of results from the Phase 3 BEACON CRC trial evaluating the combination of BRAFTOVI (encorafenib), a BRAF... Read More
Monday July 8, 2019
Array BioPharma to be acquired by drug giant Pfizer for $11.4B
BOULDER -- Drug manufacturing giantPfizer and Array BioPharma today announced they have entered into a definitive merger agreement under which Pfizer will acquire Array, a Boulder-based... Read More
Monday June 17, 2019
Array BioPharma drugs recommended by National Comprehensive Cancer Network for CR care
BOULDER -- Array BioPharma Inc. (NASDAQ: ARRY) announced the National Comprehensive Cancer Network(NCCN) has updated their Clinical Practice Guidelines in Oncology for Colon and Rectal Cancer to... Read More
Tuesday March 19, 2019
Array BioPharma announces positive results for cancer drug combo
BOULDER -- Array BioPharma Inc . (Nasdaq: ARRY) today announced updated safety and efficacy results, including mature overall survival (OS), from the safety lead-in of the Phase 3 BEACON CRC... Read More
Tuesday January 15, 2019
European Commission approves Array's encorafenib and binimetinib combo for melanoma treatment
BOULDER -- Array BioPharma Inc . (NASDAQ: ARRY) today announced the European Commission (EC) has approved BRAFTOVI (encorafenib) in combination with MEKTOVI (binimetinib) for the treatment of... Read More
Friday September 21, 2018
Array BioPharma names Carrie S. Cox chair of its board of directors
BOULDER -- Array BioPharma Inc. (Nasdaq: ARRY) today announced Carrie S. Cox has been named chair of its board of directors effective immediately. Cox has been appointed to the Audit and... Read More
Tuesday August 14, 2018
IN Sponsors
Browse
Entrepreneurial by Nature
